Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV: A Randomized Controlled Trial

Patients with HIV exhibit platelet activation and increased risk of cardiovascular disease, the prevention of which is not fully known. Fifty-five HIV-positive patients were randomized to clopidogrel, aspirin, or no-treatment for 14 days, and the platelet phenotype and ability to induce endothelial...

Descripción completa

Detalles Bibliográficos
Autores principales: Marcantoni, Emanuela, Garshick, Michael S., Schwartz, Tamar, Ratnapala, Nicole, Cambria, Matthew, Dann, Rebecca, O’Brien, Meagan, Heguy, Adriana, Berger, Jeffrey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research - Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849466/
https://www.ncbi.nlm.nih.gov/pubmed/36687270
http://dx.doi.org/10.1016/j.jacbts.2022.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9849466/
https://www.ncbi.nlm.nih.gov/pubmed/36687270
http://dx.doi.org/10.1016/j.jacbts.2022.06.002

Ejemplares similares